Search

Stephen Johnson

Examiner (ID: 7683, Phone: (571)272-6877 , Office: P/3641 )

Most Active Art Unit
3641
Art Unit(s)
2201, 3641
Total Applications
3122
Issued Applications
2552
Pending Applications
138
Abandoned Applications
437

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5687858 [patent_doc_number] => 20060286173 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-21 [patent_title] => 'Drug delivery system for sub-tenon s capsule adminstration of fine grains' [patent_app_type] => utility [patent_app_number] => 10/568892 [patent_app_country] => US [patent_app_date] => 2004-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4504 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20060286173.pdf [firstpage_image] =>[orig_patent_app_number] => 10568892 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/568892
Drug delivery system for sub-tenon s capsule adminstration of fine grains Aug 19, 2004 Abandoned
Array ( [id] => 5835389 [patent_doc_number] => 20060247220 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-02 [patent_title] => 'Preventing the crystallization of cholesterol using oxysterols' [patent_app_type] => utility [patent_app_number] => 10/568676 [patent_app_country] => US [patent_app_date] => 2004-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1658 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20060247220.pdf [firstpage_image] =>[orig_patent_app_number] => 10568676 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/568676
Preventing the crystallization of cholesterol using oxysterols Aug 18, 2004 Abandoned
Array ( [id] => 5590520 [patent_doc_number] => 20060039971 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-23 [patent_title] => 'Effervescent composition including alternative hormone replacement therapy agent' [patent_app_type] => utility [patent_app_number] => 10/921698 [patent_app_country] => US [patent_app_date] => 2004-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4066 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20060039971.pdf [firstpage_image] =>[orig_patent_app_number] => 10921698 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/921698
Effervescent composition including alternative hormone replacement therapy agent Aug 18, 2004 Abandoned
Array ( [id] => 7024965 [patent_doc_number] => 20050019359 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-27 [patent_title] => 'Cosmetic films' [patent_app_type] => utility [patent_app_number] => 10/919736 [patent_app_country] => US [patent_app_date] => 2004-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6505 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20050019359.pdf [firstpage_image] =>[orig_patent_app_number] => 10919736 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/919736
Cosmetic films Aug 16, 2004 Abandoned
Array ( [id] => 7145650 [patent_doc_number] => 20050119262 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-02 [patent_title] => 'Method for preventing or treating an optic neuropathy with a cox-2 inhibitor and an intraocular pressure reducing agent' [patent_app_type] => utility [patent_app_number] => 10/919835 [patent_app_country] => US [patent_app_date] => 2004-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16149 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20050119262.pdf [firstpage_image] =>[orig_patent_app_number] => 10919835 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/919835
Method for preventing or treating an optic neuropathy with a cox-2 inhibitor and an intraocular pressure reducing agent Aug 16, 2004 Abandoned
Array ( [id] => 7088585 [patent_doc_number] => 20050008697 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-13 [patent_title] => 'Oral solid solution formulation of a poorly water-soluble active substance' [patent_app_type] => utility [patent_app_number] => 10/915560 [patent_app_country] => US [patent_app_date] => 2004-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4203 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20050008697.pdf [firstpage_image] =>[orig_patent_app_number] => 10915560 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/915560
Oral solid solution formulation of a poorly water-soluble active substance Aug 10, 2004 Abandoned
Array ( [id] => 7033188 [patent_doc_number] => 20050031697 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-10 [patent_title] => 'Compositions for delivery of therapeutics into the eyes and methods for making and using same' [patent_app_type] => utility [patent_app_number] => 10/911966 [patent_app_country] => US [patent_app_date] => 2004-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 12937 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20050031697.pdf [firstpage_image] =>[orig_patent_app_number] => 10911966 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/911966
Compositions for delivery of therapeutics into the eyes and methods for making and using same Aug 4, 2004 Issued
Array ( [id] => 5873163 [patent_doc_number] => 20060165793 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-27 [patent_title] => 'Pharmaceutical preparation to be dispersed before administration' [patent_app_type] => utility [patent_app_number] => 10/564402 [patent_app_country] => US [patent_app_date] => 2004-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5177 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20060165793.pdf [firstpage_image] =>[orig_patent_app_number] => 10564402 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/564402
Pharmaceutical preparation to be dispersed before administration Aug 3, 2004 Abandoned
Array ( [id] => 7088591 [patent_doc_number] => 20050008703 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-13 [patent_title] => 'Medical formulation containing a muscarinic agonist' [patent_app_type] => utility [patent_app_number] => 10/909772 [patent_app_country] => US [patent_app_date] => 2004-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2936 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20050008703.pdf [firstpage_image] =>[orig_patent_app_number] => 10909772 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/909772
Medical formulation containing a muscarinic agonist Aug 1, 2004 Abandoned
Array ( [id] => 7088586 [patent_doc_number] => 20050008698 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-13 [patent_title] => 'Base material for dry direct tableting comprising low-substituted hydroxypropyl cellulose' [patent_app_type] => utility [patent_app_number] => 10/909236 [patent_app_country] => US [patent_app_date] => 2004-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3663 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20050008698.pdf [firstpage_image] =>[orig_patent_app_number] => 10909236 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/909236
Base material for dry direct tableting comprising low-substituted hydroxypropyl cellulose Jul 29, 2004 Abandoned
Array ( [id] => 5769495 [patent_doc_number] => 20060020044 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-26 [patent_title] => 'Methods and compositions for treating or preventing macular-degeneration related disorders' [patent_app_type] => utility [patent_app_number] => 10/898893 [patent_app_country] => US [patent_app_date] => 2004-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6817 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20060020044.pdf [firstpage_image] =>[orig_patent_app_number] => 10898893 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/898893
Methods and compositions for treating or preventing macular-degeneration related disorders Jul 25, 2004 Abandoned
Array ( [id] => 7010494 [patent_doc_number] => 20050064210 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-24 [patent_title] => 'Coating for use with medical devices and method of making same' [patent_app_type] => utility [patent_app_number] => 10/900016 [patent_app_country] => US [patent_app_date] => 2004-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3370 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20050064210.pdf [firstpage_image] =>[orig_patent_app_number] => 10900016 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/900016
Coating for use with medical devices and method of making same Jul 25, 2004 Abandoned
Array ( [id] => 7435419 [patent_doc_number] => 20040266792 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-30 [patent_title] => 'Hydroxyrisperidone compositions and methods' [patent_app_type] => new [patent_app_number] => 10/891236 [patent_app_country] => US [patent_app_date] => 2004-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3228 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20040266792.pdf [firstpage_image] =>[orig_patent_app_number] => 10891236 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/891236
Hydroxyrisperidone compositions and methods Jul 12, 2004 Abandoned
Array ( [id] => 10031011 [patent_doc_number] => 09072311 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-07-07 [patent_title] => 'Absorption of fat-soluble nutrients' [patent_app_type] => utility [patent_app_number] => 10/530598 [patent_app_country] => US [patent_app_date] => 2004-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6399 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10530598 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/530598
Absorption of fat-soluble nutrients Jun 20, 2004 Issued
Array ( [id] => 5034248 [patent_doc_number] => 20070098787 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-03 [patent_title] => 'Composition for preventing and treating varicose veins of lower extremities' [patent_app_type] => utility [patent_app_number] => 10/561274 [patent_app_country] => US [patent_app_date] => 2004-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5702 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20070098787.pdf [firstpage_image] =>[orig_patent_app_number] => 10561274 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/561274
Composition for preventing and treating varicose veins of lower extremities Jun 17, 2004 Abandoned
Array ( [id] => 5000372 [patent_doc_number] => 20070043006 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-22 [patent_title] => 'Formulations of non-steroidal anti-inflammatory agents to treat pathologic ocular angiogenesis' [patent_app_type] => utility [patent_app_number] => 10/557133 [patent_app_country] => US [patent_app_date] => 2004-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3682 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0043/20070043006.pdf [firstpage_image] =>[orig_patent_app_number] => 10557133 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/557133
Formulations of non-steroidal anti-inflammatory agents to treat pathologic ocular angiogenesis Jun 13, 2004 Abandoned
Array ( [id] => 5827177 [patent_doc_number] => 20060062857 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-23 [patent_title] => 'Method of producing eggshell powder' [patent_app_type] => utility [patent_app_number] => 10/535779 [patent_app_country] => US [patent_app_date] => 2004-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5025 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0062/20060062857.pdf [firstpage_image] =>[orig_patent_app_number] => 10535779 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/535779
Method of producing eggshell powder May 27, 2004 Issued
Array ( [id] => 5727615 [patent_doc_number] => 20060058376 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-16 [patent_title] => 'Composition having autonomic nerve modulating activity and method of use thereof' [patent_app_type] => utility [patent_app_number] => 10/544490 [patent_app_country] => US [patent_app_date] => 2004-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5643 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20060058376.pdf [firstpage_image] =>[orig_patent_app_number] => 10544490 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/544490
Composition having autonomic nerve modulating activity and method of use thereof May 26, 2004 Abandoned
Array ( [id] => 5689079 [patent_doc_number] => 20060287394 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-21 [patent_title] => 'Composition and method for treating macular disorders' [patent_app_type] => utility [patent_app_number] => 10/557170 [patent_app_country] => US [patent_app_date] => 2004-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4725 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20060287394.pdf [firstpage_image] =>[orig_patent_app_number] => 10557170 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/557170
Composition and method for treating macular disorders May 25, 2004 Abandoned
Array ( [id] => 7409640 [patent_doc_number] => 20040176290 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-09 [patent_title] => 'Anti-angiogenic state in mice and humans with retinal photorecptor cell degeneration' [patent_app_type] => new [patent_app_number] => 10/484550 [patent_app_country] => US [patent_app_date] => 2004-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10875 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20040176290.pdf [firstpage_image] =>[orig_patent_app_number] => 10484550 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/484550
Anti-angiogenic state in mice and humans with retinal photorecptor cell degeneration May 10, 2004 Abandoned
Menu